share_log

Merit Medical Systems (NASDAQ:MMSI) Upgraded to Strong-Buy by StockNews.com

Merit Medical Systems (NASDAQ:MMSI) Upgraded to Strong-Buy by StockNews.com

優點醫療系統公司(納斯達克代碼:MMSI)升級為Strong-Buy by StockNews.com
Defense World ·  2023/01/03 03:21

Merit Medical Systems (NASDAQ:MMSI – Get Rating) was upgraded by equities research analysts at StockNews.com from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Tuesday.

在週二發給投資者的一份研究報告中,斯托克新聞網的股票研究分析師將優點醫療系統公司(納斯達克代碼:MMSI-GET評級)的評級從“買入”上調至“強力買入”。

Several other equities research analysts have also recently commented on MMSI. Canaccord Genuity Group boosted their target price on Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. TheStreet upgraded shares of Merit Medical Systems from a "c+" rating to a "b-" rating in a research report on Friday, September 16th. Raymond James lifted their price target on shares of Merit Medical Systems from $71.00 to $72.00 and gave the stock an "outperform" rating in a research report on Thursday, October 27th. Canaccord Genuity Group lowered shares of Merit Medical Systems from a "buy" rating to a "hold" rating and decreased their price target for the stock from $73.00 to $72.00 in a research report on Tuesday, December 20th. Finally, Piper Sandler lifted their price objective on shares of Merit Medical Systems from $70.00 to $73.00 in a research report on Thursday, October 27th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $73.50.

其他幾位股票研究分析師最近也對MMSI發表了評論。在11月7日星期一的一份報告中,Canaccel Genuity Group將Merit Medical Systems的目標價從69.00美元上調至73.00美元。華爾街在9月16日星期五的一份研究報告中將Merit Medical Systems的股票評級從“c+”上調至“b-”。雷蒙德·詹姆斯在10月27日(星期四)的一份研究報告中將Merit Medical Systems的股票目標價從71.00美元上調至72.00美元,並給予該股“跑贏大盤”的評級。在12月20日星期二的一份研究報告中,Canaccel Genuity Group將Merit Medical Systems的股票評級從買入下調至持有,並將該股的目標價從73.00美元下調至72.00美元。最後,在10月27日星期四的一份研究報告中,派珀·桑德勒將Merit Medical Systems的股票目標價從70.00美元上調至73.00美元。一位研究分析師對該股的評級為持有,四位分析師發佈了買入評級,一位分析師對該公司給予了強烈的買入評級。根據MarketBeat的數據,該公司目前的平均評級為“買入”,共識目標價為73.50美元。

Get
到達
Merit Medical Systems
優點醫療系統
alerts:
警報:

Merit Medical Systems Price Performance

優點醫療系統性價比

Shares of NASDAQ:MMSI opened at $70.62 on Tuesday. Merit Medical Systems has a 12 month low of $50.46 and a 12 month high of $76.14. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 65.39, a PEG ratio of 2.50 and a beta of 1.01. The stock's 50 day moving average price is $69.92 and its 200 day moving average price is $61.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.35 and a quick ratio of 1.19.

納斯達克:微星週二開盤報70.62美元。優點醫療系統公司的12個月低點為50.46美元,12個月高位為76.14美元。該股市值為40.2億美元,市盈率為65.39倍,市盈率為2.50倍,貝塔係數為1.01。該股的50日移動均線價格為69.92美元,200日移動均線價格為61.61美元。該公司的債務權益比為0.19,流動比率為2.35,速動比率為1.19。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last announced its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 EPS for the quarter, topping the consensus estimate of $0.53 by $0.11. Merit Medical Systems had a return on equity of 14.14% and a net margin of 5.43%. The firm had revenue of $287.18 million for the quarter, compared to analysts' expectations of $273.03 million. Equities research analysts anticipate that Merit Medical Systems will post 2.57 earnings per share for the current fiscal year.
優點醫療系統公司(納斯達克代碼:MMSI-GET Rating)最近一次公佈財報是在10月26日星期三。這家醫療器械供應商公佈本季度每股收益為0.64美元,比普遍預期的0.53美元高出0.11美元。優點醫療系統公司的股本回報率為14.14%,淨利潤率為5.43%。該公司本季度營收為2.8718億美元,高於分析師預期的2.7303億美元。股票研究分析師預計,Merit Medical Systems本財年每股收益將達到2.57美元。

Hedge Funds Weigh In On Merit Medical Systems

對衝基金看好Merit醫療系統

Institutional investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC boosted its stake in Merit Medical Systems by 746.0% during the second quarter. SG Americas Securities LLC now owns 27,013 shares of the medical instruments supplier's stock worth $1,466,000 after acquiring an additional 23,820 shares in the last quarter. Rhumbline Advisers increased its holdings in Merit Medical Systems by 8.8% during the second quarter. Rhumbline Advisers now owns 143,882 shares of the medical instruments supplier's stock worth $7,808,000 after buying an additional 11,616 shares during the last quarter. Maryland State Retirement & Pension System boosted its position in Merit Medical Systems by 1.4% during the second quarter. Maryland State Retirement & Pension System now owns 20,671 shares of the medical instruments supplier's stock worth $1,122,000 after purchasing an additional 295 shares during the period. Nisa Investment Advisors LLC boosted its position in shares of Merit Medical Systems by 17.5% in the second quarter. Nisa Investment Advisors LLC now owns 4,337 shares of the medical instruments supplier's stock valued at $235,000 after acquiring an additional 647 shares during the period. Finally, M&T Bank Corp lifted its position in Merit Medical Systems by 67.3% during the second quarter. M&T Bank Corp now owns 26,191 shares of the medical instruments supplier's stock valued at $1,422,000 after purchasing an additional 10,535 shares during the last quarter. 95.38% of the stock is currently owned by institutional investors and hedge funds.

機構投資者最近增持或減持了該股。第二季度,SG America Securities LLC將其在Merit Medical Systems的持股增加了746.0%。SG America Securities LLC現在擁有這家醫療器械供應商27,013股股票,價值1,466,000美元,上個季度又收購了23,820股。Rhumbline Advisers在第二季度增持了Merit Medical Systems 8.8%的股份。在上個季度又購買了11,616股後,Rhumbline Advisers現在擁有這家醫療器械供應商143,882股股票,價值7,808,000美元。馬裏蘭州退休和養老金系統在第二季度將其在Merit醫療系統的地位提高了1.4%。馬裏蘭州退休和養老金系統現在擁有這家醫療器械供應商的20,671股股票,價值1,122,000美元,在此期間又購買了295股。NISA Investment Advisors LLC在第二季度將其在Merit Medical Systems的股票頭寸增加了17.5%。NISA Investment Advisors LLC現在擁有這家醫療器械供應商4337股股票,價值23.5萬美元,在此期間又購買了647股。最後,M&T Bank Corp在第二季度將其在Merit Medical Systems的頭寸提高了67.3%。M&T銀行(M&T Bank Corp)目前持有這家醫療器械供應商26,191股股票,價值1,422,000美元,此前該公司在上一季度又購買了10,535股。95.38%的股票目前由機構投資者和對衝基金持有。

About Merit Medical Systems

關於功德醫療系統公司

(Get Rating)

(獲取評級)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

優點醫療系統公司設計、開發、製造和營銷用於介入、診斷和治療程序的一次性醫療產品,主要用於心臟病學、放射學、腫瘤學、危重護理和內窺鏡檢查。該公司在心血管和內窺鏡兩個領域開展業務。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • Ready for a Recession? Here's One Defensive Stock You Can't Miss
  • Should You Store Your Capital in Pure Storage Stock?
  • Is it Time to Back up the Truck on Ford Stock?
  • Analysts Ring In The New Year With These 2 Q3 Winners
  • Walt Disney Stock Looks Marvelous Down
  • 免費獲取StockNews.com關於Merit Medical Systems(MMSI)的研究報告
  • 準備好迎接經濟衰退了嗎?這裏有一隻你不能錯過預期的防禦性股票
  • 您是否應該將您的資本存儲在純存儲股票中?
  • 現在是時候支持福特股票的卡車了嗎?
  • 分析師與這兩位第三季度獲勝者一起迎接新年
  • 華特迪士尼股票看起來令人驚訝地下跌

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新聞和評級的優點醫療系統每日-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Merit Medical Systems和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論